Literature DB >> 16839326

Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II--proposals for DSM-V and ICD-11.

Marcel D Waldinger1, Dave H Schweitzer2.   

Abstract

BACKGROUND: In the Diagnostic and Statistical Manual of Mental Disorders (DSM), a descriptive definition for premature ejaculation (PE) that was based on historical assumptions has been accepted. AIM: To formulate a new functional definition of PE in the DSM.
METHODS: A "syndrome" approach instead of a "complaint" approach is applied and evidence-based data from epidemiological and clinical studies are used.
RESULTS: A new functional definition of PE should pertain to a cluster of "symptoms" of a distinct "syndrome." A syndrome rather than a descriptive definition should distinguish Lifelong and Acquired PE variants. Evidence-based data also suggest another PE type "Natural Variable PE," which is not a typical syndrome but rather a cluster of inconsistent symptoms of rapid ejaculation. Moreover, in "Natural Variable PE" the occurrence of rapid ejaculation is not based on neurobiological or psychological pathology, but belongs to the normal variability of sexual performance. Its prevalence is probably much higher than that of Lifelong and Acquired PE. We propose three separate operationalized definitions of these three PE types for the pending DSM-V and ICD-11, which include a quantification of the ejaculation time (intravaginal ejaculation latency time), inability of ejaculatory control, and a description of severity of PE in terms of psychological distress.
CONCLUSION: The use of the intravaginal ejaculation latency time into the DSM-V and ICD-11 would mean that statistical evidence becomes accepted as one of the mainstays for establishing an evidence-based definition of the three PE types.

Entities:  

Mesh:

Year:  2006        PMID: 16839326     DOI: 10.1111/j.1743-6109.2006.00276.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  42 in total

1.  Medical therapy for premature ejaculation.

Authors:  Amar Mohee; Ian Eardley
Journal:  Ther Adv Urol       Date:  2011-10

Review 2.  Advances in understanding and treating premature ejaculation.

Authors:  Theodore R Saitz; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2015-10-27       Impact factor: 14.432

Review 3.  Premature ejaculation: definition and drug treatment.

Authors:  Marcel D Waldinger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  The association of anxiety with the subtypes of premature ejaculation: a chart review.

Authors:  Ravi Philip Rajkumar; Arun Kumar Kumaran
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-31

5.  Sexual dysfunction: anesthetic spray improves premature ejaculation.

Authors:  Chris G McMahon
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

6.  Dapoxetine: a new option in the medical management of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Ther Adv Urol       Date:  2012-10

7.  Transcutaneous functional electrical stimulation-a novel therapy for premature ejaculation: results of a proof of concept study.

Authors:  Arik Shechter; E C Serefoglu; Tal Gollan; Shmuel Springer; Gideon Meiry; Boaz Appel; Ilan Gruenwald
Journal:  Int J Impot Res       Date:  2019-09-30       Impact factor: 2.896

Review 8.  Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity.

Authors:  Elena Colonnello; Giacomo Ciocca; Erika Limoncin; Andrea Sansone; Emmanuele A Jannini
Journal:  Nat Rev Urol       Date:  2021-01-13       Impact factor: 14.432

Review 9.  New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.

Authors:  Ege C Serefoglu; Theodore R Saitz
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

10.  A reassessment of penile sensory pathways and effects of prilocaine-lidocaine cream in primary premature ejaculation.

Authors:  J-D Xia; L-H Zhou; Y-F Han; Y Chen; R Wang; Y-T Dai
Journal:  Int J Impot Res       Date:  2014-02-27       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.